HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticardiolipin antibody in women with recurrent spontaneous miscarriage.

AbstractOBJECTIVE:
To determine the association between the presence of anticardiolipin antibody (ACA) and history of recurrent spontaneous miscarriage. Also, to evaluate the association between raised ACA and activated partial thromboplastin time (APTT).
METHODS:
This is a case-control study which was carried out in Basrah Hospital for Maternity and Children, Basrah, Iraq during January to September 2004 on 91 women with recurrent spontaneous miscarriage, matched with 109 women with no history of pregnancy wastage. Sera were collected from these 200 women and analyzed for ACA by enzyme linked immunosorbent assay (ELISA).
RESULTS:
In women with pregnancies that ended with a loss, 17.6% were positive of ACA, compared with none among the control group. Women with 4 or more miscarriages had almost higher percentages of ACA (26.3% and 22.2%) than women with only 3 miscarriages (13%) but with no statistical significance. Prolonged APTT was detected among 18.8% of patients having positive ACA while only 1.6% of patients who were negative for this antibody.
CONCLUSION:
A significant association was observed between recurrent spontaneous miscarriage and the presence of ACA. Also, there was a significant relationship between positive ACA and prolonged APTT.
AuthorsIlham M Jwad, Nadham K Mahdi, Maysoon S Flafil
JournalSaudi medical journal (Saudi Med J) Vol. 27 Issue 9 Pg. 1387-90 (Sep 2006) ISSN: 0379-5284 [Print] Saudi Arabia
PMID16951778 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Anticardiolipin
Topics
  • Abortion, Habitual (blood)
  • Adolescent
  • Adult
  • Antibodies, Anticardiolipin (blood)
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Middle Aged
  • Partial Thromboplastin Time
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: